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Background: PFA0210c is an exported Plasmodium falciparum protein.
Results: PFA0210c is a phospholipid transfer protein with similarities to proteins of the family of START domain-containing
proteins and can transfer various phospholipids between membranes in vitro.
Conclusion: PFA0210c and its orthologs are phospholipid transfer proteins with a broad specificity.
Significance: Identification of the function of conserved Plasmodium proteins allows deeper insight into the basis of
pathogenesis.
Infection of erythrocytes by the humanmalaria parasite Plas-
modium falciparum results in dramatic modifications to the
host cell, including changes to its antigenic and transport prop-
erties and the de novo formation ofmembranous compartments
within the erythrocyte cytosol. These parasite-induced struc-
tures are implicated in the transport of nutrients, metabolic
products, and parasite proteins, as well as in parasite virulence.
However, very few of the parasite effector proteins that underlie
remodeling of the host erythrocyte are functionally character-
ized. Using bioinformatic examination and modeling, we have
found that the exported P. falciparum protein PFA0210c
belongs to the START domain family, members of which medi-
ate transfer of phospholipids, ceramide, or fatty acids between
membranes. In vitro phospholipid transfer assays using recom-
binant PFA0210 confirmed that it can transfer phosphatidyl-
choline, phosphatidylinositol, phosphatidylethanolamine, and
sphingomyelin between phospholipid vesicles. Furthermore,
assays using HL60 cells containing radiolabeled phospholipids
indicated that orthologs of PFA0210c can also transfer phos-
phatidylcholine, phosphatidylinositol, and phosphatidyletha-
nolamine. Biochemical and immunochemical analysis showed
that PFA0210c associates with membranes in infected erythro-
cytes atmature stages of intracellular parasite growth. Localiza-
tion studies in live parasites revealed that the protein is present
in the parasitophorous vacuole during growth and is later
recruited to organelles in the parasite. Together these data sug-
gest that PFA0210c plays a role in the formation of themembra-
nous structures and nutrient phospholipid transfer in the
malaria-parasitized erythrocyte.
Plasmodium falciparum is the causative agent of malaria, a
disease that claims nearly one million lives each year (1, 2). All
symptoms of malaria result from infection of erythrocytes by
the parasite, so investigating interactions between the parasite
and its host cell is of great importance to understanding of the
disease. The parasite actively invades the erythrocyte and
comes to rest within a membrane-bound parasitophorous vac-
uole (PV).3 The intracellular parasite develops into a trophozo-
ite, which replicates asexually by a process called schizogony,
gradually expanding to fill an increasing proportion of the host
cell volume. Eventually, at 48 h post-invasion, the schizont
undergoes segmentation to produce 16–32 progeny merozo-
ites that are released upon rupture of the infected cell to repeat
the cycle.
The parasitized erythrocyte undergoes a range of dramatic
structural changes during parasite growth, including altera-
tions to its deformability, membrane permeability, and cytoad-
hesive properties (3). Throughout its intracellular life cycle the
parasite remains surrounded by the PV membrane (PVM),
which therefore has to expand to accommodate the growing
parasite. The parasite also induces the formation of additional
membranous compartments within the cytosol of the infected
erythrocyte beyond the PV, including Maurer clefts, which are
important for the assembly of the surface-exposed knobs (4)
that alter the adhesive properties of the erythrocyte, and the
tubovesicular network, which plays an important role in nutri-
ent import (5). Furthermore, two different types of mobile ves-
icles have been identified in infected erythrocytes; the highly
mobile vesicles (6) and the J-dots (7). These structuresmay also
have a role in the transport of parasite proteins throughout the
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in assembling the PVM and other induced membrane struc-
tures in the parasite-infected erythrocyte has been identified.
A large set of parasite proteins is known to be exported
beyond the parasite plasma membrane and the PVM into the
host erythrocyte (8). Identification of these proteins was aided
by the discovery of a distinct export motif, the HT (or PEXEL)
motif (9, 10), which directs many of the exported proteins into
the host cell. Based on this motif it has been predicted that
between 422 (11) and 455 (12) proteins are exported. The upper
figure may be a conservative estimate as it has recently been
recognized that several exported proteins do not contain the
HT/PEXEL motif (13) but may be exported through the same
common pathway (14, 15). Hence the total number of exported
parasite proteins likely exceeds these estimates.
Exported P. falciparum proteins may be divided into three
categories. The first comprises species-specific proteins, which
likely have roles specific forP. falciparum andprobablymediate
specific aspects of its pathogenicity. The best studied of these is
PfEMP1, the main component of the knob structures at the
surface of the parasitized erythrocyte that are required for vas-
cular sequestration. The second category comprises host-spe-
cific exported proteins, which are found only in Plasmodium
species that infect humans and likely play roles in the interac-
tion with the host. A third category comprises several exported
proteins that are found in all sequenced Plasmodium species
(11, 12). These likely perform important, conserved functions
in the interaction of the parasite with the host cell and may
represent the basic machinery that allows the parasite to sur-
vive inside the erythrocyte. However, the absence of obvious
sequence similarity between exported malarial proteins and
proteins in the databases means that the biochemical function
of most of the exported parasite proteins is unknown.
Here we describe an investigation of the P. falciparum pro-
tein PFA0210c (current PlasmoDB ID PF3D7_0104200), previ-
ously identified by us (9) as one of the subset of exported pro-
teins conserved in allPlasmodium species examined (11). Using
bioinformatic and biochemical approaches, we demonstrate
that PFA0210c is a member of the family of steroidogenic
acute regulatory protein-related lipid transfer (START)
domain-containing phospholipid transfer proteins. We show
that PFA0210c is expressed during the asexual intraerythro-
cytic life cycle, associates withmembranes, and has the capacity
to transfer phospholipids between phospholipid vesicles.
EXPERIMENTAL PROCEDURES
Cloning and Expression Constructs—Gene fragments of
PFA0210c, PKH_020910, and PCHAS_020730 were amplified
from genomic DNA by PCR using the primers listed in supple-
mental Table S1. The resulting fragments were digested with
EcoRI and XhoI and cloned into pMAL c2x (New England Bio-
labs) that had been digested with EcoRI and SalI. The resulting
plasmids encode a fusion protein withmaltose-binding protein
(MBP) at the N terminus and a C-terminal hexahistidine (His6)
tag. Point mutations were produced by overlapping PCR using
the primers listed in supplemental Table S1. The PCR frag-
ments were fused in a second PCR step using both amplicons as
templates in conjunction with external primers (supplemental
Table S1). The resulting DNAwas further amplified with prim-
ers CVO022 and CVO023 and cloned into pMAL c2x as
described above. An additional 5 sequence was added by clon-
ing the EcoRV-BsrGI fragment from pBLD368 into the result-
ing plasmids.
Protein Purification—Recombinant proteins were purified as
MBP-His6 fusions from Escherichia coli BL21. Protein produc-
tion was induced by addition of isopropyl -D-1-thiogalactopy-
ranoside (0.5 mM) to bacterial cultures, which were then grown
overnight at 18 °C. The cultures were harvested by centrifuga-
tion, followed by suspension in high salt MBP buffer (20 mM
Tris-HCl, pH 7.4, 0.5 M NaCl) containing protease inhibitors
(Complete EDTA-free Mixture, Roche Applied Science) and
lysed with a Cell Disruptor (Constant Cell Disruption System).
The lysate was sonicated for three cycles of 30 s, setting 4, 50%
duty cycle with a microtip (Vibracell, Sonics and Materials,
Inc.) and subsequently centrifuged twice in anOakridge tube at
9,000  g for 30 min in a JA25.5 rotor. The supernatant was
then transferred to a 50-ml conical tube containing 0.5–1.0 ml
of Ni2-NTA resin (Qiagen), and mixed at 4 °C for 2 h. The
resinwas transferred to a 1.5 12-cmchromatography column
(Bio-Rad), washedwith100 columnvolumes of high saltMBP
buffer containing 25 mM imidazole, then bound protein was
eluted with 10 ml of high salt MBP buffer containing 250 mM
imidazole. For the time course and titration experiments, the
Ni2-NTA eluate was polished by gel filtration chromatogra-
phy on aHiLoad 26/60 Superdex 200 prep-grade column equil-
ibrated in standard assay buffer (10 mM HEPES-Na, 1 mM
EDTA-Na, 50mMNaCl, pH 7.4). Peak protein fractions were
identified by SDS-PAGE and Coomassie staining, and con-
centrated using a 30-kDamolecular mass cut-off Vivaspin 15
concentrator (Sartorium Stedim Biotech). The protein con-
centration was determined using a Nanodrop 1000 (Thermo
Scientific) and the concentrated protein was stored at 4 °C
for up to 2 weeks without a noticeable decrease in activity. To
purify recombinant proteins used for the remaining transfer
assays, the Ni2-NTA eluate was added to 1 ml of amylose
resin (New England Biolabs) and incubated at 4 °C overnight
with agitation. The resin was poured into a 1.5 12-cm chro-
matography column (Bio-Rad), washed with100 column vol-
umes ofMBP buffer (20 mMTris-HCl, pH 7.4, 0.2 M NaCl), and
bound protein was eluted with 10 ml of MBP buffer containing
50 mM maltose. The eluate was dialyzed against standard assay
buffer (10 mM HEPES-Na, 1 mM EDTA-Na, 50 mM NaCl, pH
7.4) using Slide-A-Lyzer cassettes (Thermo Scientific) with a
molecular mass cut-off of 20,000 Da. The protein was subse-
quently concentrated and the concentration was established as
described above. The proteins were divided into aliquots, snap
frozen in a dry ice-ethanol bath, and stored at 80 °C. After
thawing, the proteins were stored at 4 °C and used for up to 2
weeks.
MBP-LacZ was purified similar to MBP-PFA0210c-His6,
except that the bacterial lysate, after centrifugation, was loaded
directly onto amylose resin and the proteinwas dialyzed against
PBS using Slide-A-Lyzer cassettes (Thermo Scientific). It was
then concentrated and frozen as described forMBP-PFA0210c-
His6. Rat phosphatidylinositol transfer protein  (PITP) was
purified as described previously (16).
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Secondary Structure Predictions and Structure-basedHomol-
ogy Determination—The predicted PFA0210c primary amino
acid sequencewas submitted to theProfileBasedFoldRecognition
predictionmethod pGenTHREADER (17) (UCL, Bioinformatics
Group) to generate modeling alignments of PFA0210c with
homologous or related proteins from the Protein Data Bank
(PDB).
Antibodies and Monoclonal Antibody Production—Mono-
clonal antibodies 24C6.1F1 (a kind gift of Jean-Francois
Dubremetz, University of Montpellier 2) and X509, reactive
with P. falciparum proteins SERA5 and MSP1, respectively, have
been described previously (18, 19). To detect the HA epitope on
Westernblots,mAb3F10wasused.Theanti-PFA0210cmonoclo-
nal antibody (mAb) NIMP.M11 (subclass IgG1 as determined by
Ouchterlony assay) was produced using splenic B cells obtained
from BALB/c mice immunized with recombinant protein MBP-
PFA0210c-His6 purified as described above. The cells were
fused with Sp2/0/Ag14 myeloma cells and cloned by limiting
dilution using standard procedures, screening cell supernatants
by dot blot against a glutathione S-transferase-PFA0210c
fusion protein that had been purified from E. coli on glutathi-
one-agarose (Sigma) as per the manufacturer’s instructions.
Undiluted hybridoma supernatant was used for Western blots.
Detection of PFA0210c during the Intraerythrocytic Life Cycle—
To obtain parasite extract over the course of one intraerythro-
cytic cycle, six small flasks containing a low hematocrit (1%)
infected at a high parasitemia (20–30%) with P. falciparum
clone 3D7 in 10 ml of RPMI containing Albumax were set up.
To ensure that the parasites were synchronized, the erythro-
cyteswere infectedwith Percoll-purified schizonts for 1 h.After
this period, residual schizonts were removed on a Percoll gra-
dient and any remaining schizontswere lysed by treatmentwith
5% (w/v) sorbitol. At the indicated time points a culture was
pelleted by centrifugation, and transferred to two microcentri-
fuge tubes, washed once with 900 l of PBS and stored at
80 °C. ForWestern blot analysis, each sample was solubilized
directly into 200 l of 1.2  SDS-PAGE loading buffer and
fractionated on 10% SDS-polyacrylamide gels. Proteins were
transferred to nitrocellulose (Hybond-C Extra, GE Healthcare)
and detected using the anti-PFA0210c mAb NIMP.M11, an
HRP-linked secondary anti-mouse antibody, and a chemilumi-
nescence developing system (Immobilon Western Chemilu-
minuescent HRP substrate, Millipore).
Construction of P. falciparum Expression Plasmids and Par-
asite Lines—pBLD390 was produced by amplifying the 5 and
3 regions of PFA0210c by PCR with primer pairs CVO001
and CVO002 and CVO024 and CVO023, respectively. The
His6-HA3-GFP module was amplified from a version of
pHH1SERA5chimWT (20) in which the His6-HA3-GFP mod-
ule was inserted using primers CVO003 and CVO004. The
three fragmentswere joined in one PCRusing primersCVO001
and CVO023. The resulting DNA fragment was cloned into
pGEM-T according to the supplier’s instructions and subse-
quently cloned into pBLD210 (11). pBLD397 was produced by
amplifying PFA0210c and 1938 bases of its upstream flanking
(promoter) region using primers CVO030 and CVO023. The
resulting fragment was cloned into pGEM-T according to the
supplier’s instructions. The His6-HA3-GFP module was intro-
duced into the resulting plasmid by transferring a BstZ17I frag-
ment and a BstZ17I-XhoI fragment frompBLD390.The resulting
fusionwas subsequently cloned into pA289 (a kind gift of Andrew
Osborne) fromwhich the SalI-CelII fragment, containing the cal-
modulin promoter, was removed using SpeI and XhoI.
PfBLD390 was created by transfecting schizonts of P. falcip-
arum strain 3D7 with pBLD390 according to the protocol
described by Moon et al. (21). PfBLD397 was created by trans-
fecting the P. falciparum 3D7 strain containing a genomic inte-
grated attB cassette (22) with pBLD397 and pINT, whichmedi-
ates expression of the Bxb1 integrase in P. falciparum (22).
Transfectants were selected with WR99210 in the case of
PfBLD390 and blasticidin in the case of PfBLD397.
Parasite Extract Production and Fractionation,Western Blot-
ting, and Streptolysin O Treatment—Percoll-enriched schiz-
onts that had been frozen at80 °C were thawed directly into
hypotonic lysis buffer (10 mM Tris-HCl, pH 8.0, 5 mM EDTA)
containing protease inhibitors. The lysate was incubated on ice
for 90 min with occasional agitation, then divided into two ali-
quots and centrifuged at 100,000  g in a Beckman TL-100
centrifuge using a TLA100.3 rotor. The supernatants contain-
ing soluble extract proteins were retained and the pellets were
washed twice with hypotonic lysis buffer. Pellets then were
resuspended in 0.7ml of high salt buffer (50mMTris-HCl, 5mM
EDTA, 500 mM NaCl) by trituration and incubated on ice for a
further 30 min. The samples were centrifuged as before, the
supernatantswere transferred to a new tube (this represents the
membrane-associated fraction), and the pellets were resus-
pended in carbonate buffer (0.1 M sodium carbonate, pH 11) by
trituration. The samples were kept on ice and centrifuged as
before. The supernatant was transferred to a new tube and
the pelletwas resuspended in 1 SDS-PAGE loading buffer. The
samples were run on a 10% SDS-polyacrylamide gel and
the proteins transferred to nitrocellulose (Hybond-C Extra,
Amersham Biosciences). PFA0210c was detected using mAb
NIMP.M11 and SERA5 was detected in parallel using the anti-
SERA5mAb 24C6.1F1. The anti-SERA5 blot was stripped with
5% acetic acid and reprobed with the anti-MSP1 mAb X509.
Streptolysin O treatment of infected erythrocytes was per-
formed as described (23).
Phospholipid Transfer Assay—Phospholipid transfer was
measured as described previously (24), except that the volume
was reduced to 100 l and the final spin was repeated to
reduce the carry-over of pelleted vesicles. Radioactive L-[-
dipalmitoyl-1-14C]phosphatidylcholine and choline-[meth-
yl-3H]sphingomylein (egg) were obtained from PerkinElmer
Life Sciences.
Transfer of Radiolabeled Lipids to Liposomes Using Permea-
bilized HL60 Cells as a Donor—Association of cellular lipids
with the PITP proteins was analyzed using a modification of a
previously published protocol (25, 26). In brief, HL60 cells (50
ml) were labeled with 1 Ci/ml of [14C]acetate in RPMI 1640
medium for 48 h. The cells were permeabilized with streptoly-
sin O and the leaked cytosol removed by centrifugation. 200 l
of permeabilized cells (107 cells) were incubatedwith 50g of
recombinant protein or a control protein (100 l) for 60 min at
37 °C in the presence of 2 mM Mg2-ATP and 200 l of lipo-
somes (PC:PI, 98:2mol/mol, 160g of total lipid). The reaction
PFA0210c Is a P. falciparum Phospholipid Transfer Protein
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was quenched by the addition of 100l of ice-cold 0.2 M sodium
acetate, 0.25 M sucrose (pH 5.0). The tubes were vortexed and
left on ice for 10 min to aggregate the membranes. Following
centrifugation at 12,000 g for 10 min at 4 °C, 500 l of super-
natant from each reaction was transferred to microcentrifuge
tubes and further centrifuged at 100,000  g in a benchtop
ULTRA centrifuge for 1 h to remove any cellular debris. At the
end of the incubation, 400 l of the supernatant was sampled
and the lipids were extracted and resolved by analytical thin
layer chromatography (TLC) developed in chloroform:metha-
nol:acetic acid:water (75:45:3:1, by volume). The TLC plates
were imaged between 2 and 3 days using Fuji phosphorimaging
screens and data were quantified by densitometry using AIDA
software. Results are expressed as a percentage of the total input
count. Error bars indicate mean S.D.
Purification of 14C-Labeled Phosphatidylinositol and Phos-
phatidylethanolamine—14C-Labeled phosphatidylinositol and
phosphatidylethanolamine were purified from HL60 cells
grown in [14C]acetate for 72 h. Cells (200 ml) were cultured in
RPMI supplemented with 10% FCS and 1 C/ml of [14C]ac-
etate. After 72 h, the cells were pelleted by centrifugation and
the lipidswere extracted as described previously (25). The lipids
were separated on a Whatman Silica Gel 60 TLC plate using
chloroform:methanol:acetic acid:water (75:45:3:1) as the sol-
vent. The TLC plate was exposed to a FUJI BAS1000 phosphor-
imaging system for 16 h. Phosphatidylinositol and phosphati-
dylethanolamine were located using standards and the silica
containing PI and PE were scraped into glass tubes and the
lipids were extracted from the silica. The lipid extract was used
without further purification.
Live FluorescenceMicroscopy—To prepare parasites for fluo-
rescence microscopy, parasites were synchronized by adding
Percoll-enriched mature schizonts to fresh erythrocytes and
allowed to undergo invasion for1 h, after which unruptured
schizonts were removed by centrifugation on a second Percoll
gradient. A small aliquot of parasitized erythrocytes was trans-
ferred to a microcentrifuge tube at the indicated time, centri-
fuged briefly, and resuspended in PBS containing 1 g/ml of
Hoechst 33258. After 5 min the cells were washed once with
PBS and subsequently resuspended in a small volume of PBS. A
3-l aliquot was used for microscopy.
RESULTS
PFA0210c Shares Sequence and Structural Similarity with
Phospholipid Transfer Proteins—Previous in-depth analyses
have revealed that P. falciparum can export hundreds of pro-
teins to the host erythrocyte (9, 10, 12). To determine whether
the sequences of the conserved exported P. falciparum proteins
previously identified by van Ooij et al. (11) could reveal insight
into their function, we examined them using position-specific
iterative-BLAST analysis. This algorithm applies an iterative
approach to identify patterns of conservation and then uses
these patterns for subsequent searches of the protein database,
thereby allowing the identification of weakly conserved regions
(27). In the case of PFA0210c this revealed similarity with
START domain-containing 7 (StarD7), a phosphatidylcholine
transfer protein (28) (Fig. 1) involved in the transfer of phos-
phatidylcholine to mitochondria (29). Further iterations also
identified similarities between PFA0210c and STARD10, a
phospholipid transfer protein that can transfer phosphatidyl-
choline and phosphatidylethanolamine and that belongs to the
same family of START domain-containing proteins as StarD7
(30). This finding is consistent with the current annotation of
PFA0210c in PlasmoDB version 9.1 (31) as containing a domain
belonging to the Bet-v1 family, a superfamily of domains that
includes the START domain-containing proteins. The similar-
ity between PFA0210c and StarD7 extends throughout the
annotated Bet-v1 domain (residues 149 to 386, underlined in
Fig. 1), although PFA0210c possesses an additional C-terminal
extension of80 amino acid residues.
Further evidence for the inclusion of PFA0210c within the
START domain-containing protein family derived from an
alignment of human START domain-containing proteins that
revealed three absolutely conserved residues and one residue
that varied in only one protein (32). Importantly, three of these
four residues are also conserved in PFA0210c (Trp-227, Asp-
289, andArg-324; highlighted in green in supplemental Fig. S1),
whereas the fourth residue, Trp-154 in StarD7 (highlighted in
yellow in supplemental Fig. S1), is not conserved.
Structure predictions of PFA0210c using pGenTHREADER
(17, 33) identified human phosphatidylcholine transfer protein
(PDB 1LN1 (34)) (supplemental Fig. S1), STAR-related lipid
transfer protein from Xanthomonas axonopodis (PDB 3QSZ,
Northeast Structural Genomics Consortium), and the human
ceramide transport protein (CERT) (PDB 2E3N (35))4 as the
three proteins with a structure most similar to that predicted
for PFA0210c. Although primary sequence identity between
PFA0210c and the identified phospholipid transfer proteins is
low in each case (14.8, 15.3, and 11.3%, respectively), it is none-
theless significant that all three are lipid transfer proteins. We
interpret this as further evidence that PFA0210cmay also act as
a phospholipid transfer protein.
PFA0210c is conserved among all sequenced Plasmodium
species (supplemental Fig. S1). Aligning the sequence of
PFA0210c with its orthologs from P. knowlesi, which infects
primates and humans, and Plasmodium chabaudi, a rodent
malaria parasite, revealed that the sequence comprising the
putative START domain contains the highest level of conserva-
tion; similarity in this region of the protein is 56% between
PFA0210c and PKH_020910 and 48% between PFA0210c and
PCHAS_020730. Noticeably less conservation exists in other
parts of the protein; similarity over the entire length of the protein
is 38% between PFA0210c and PKH_020910 and 33% between
PFA0210c and PCHAS_020730. However, despite the low level of
similarity in the N-terminal region, all Plasmodium orthologs
examined contain a putative HT/PEXELmotif, suggesting that all
are likely to be exported as previously shown experimentally for
PFA0210c (11). Collectively, these data suggest that PFA0210c is a
conserved, exported phospholipid transfer protein.
PFA0210c Is Synthesized during theAsexual Intraerythrocytic
Life Cycle and Is Membrane Associated—Transcriptional stud-
ies have indicated that PFA0210cmRNA is present during the
intraerythrocytic cycle (36–38) and proteomic studies have
4 C. van Ooij, C. Withers-Martinez, and M. J. Blackman, unpublished data.
PFA0210c Is a P. falciparum Phospholipid Transfer Protein
31974 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 288•NUMBER 44•NOVEMBER 1, 2013
 by guest on July 28, 2015
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
FIGURE 1. PFA0210c exhibits similarity to START domain-containing proteins.Alignment of PFA0210c and STARD7. Sequences of STARD7 and PFA0210c
were aligned using the ClustalW program. Identical residues are indicated by asterisks (*), strongly similar residues by colons (:), andweakly similar residues by
dots (.). The residues conserved in an alignment of 15 human START domain-containing proteins (32) are indicated in bold and the START domains in the
proteins are shown by the underline.
FIGURE 2. PFA0210c is expressed in asexual blood-stage parasites as a membrane-associated protein. A, time course of PFA0210c synthesis. Synchro-
nous parasite cultures were analyzed at the indicated time post-invasion by Western blot using anti-PFA0210c mAb NIMP.M11. As a control an extract of
uninfected erythrocytes (Uninf.) was included. PFA0210c is detectable at very early times post-infection (2 h), is absent during the ring stage (14 h), but is
present from the mid-trophozoite stage (26 h) through to the end of the life cycle (46 h). The accumulation of lower molecular weight species recognized by
the mAb suggests that the protein is proteolytically processed. B, fractionation of parasitized erythrocytes. Soluble, peripherally membrane-associated (high
salt or 0.1 M carbonate soluble) and integral membrane or cytoskeletal (0.1 M carbonate insoluble) fractions of parasite extracts were prepared as described
under “Experimental Procedures,” then analyzed by Western blot with anti-PFA0210c mAb NIMP.M11. Full-length PFA0210c was detected in the whole cell
lysate and the carbonate-insoluble fraction, with a small amount present in the hypotonic lysate. Note that the larger of the lower molecular weight bands
detected by the anti-PFA0210mAb appears to bemembrane bound, whereas the smaller of the lower molecular weight bands appears to be soluble in high
salt extract, indicating a weaker membrane interaction. As controls, the samples were reprobed with mAb 24C6.1F1 against the soluble PV parasite protein
SERA5, as well as mAb X509 specific for the glycosylphosphatidylinositol-linked merozoite surface protein MSP1. Both control proteins were detected in the
expected fraction.
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detected PFA0210c in merozoites (39) and gametocytes (40),
indicating that the protein is produced during the asexual intra-
erythrocytic cycle as well as the sexual stages. Furthermore, a
proteomic study detected the Plasmodium vivax ortholog
PVX081550 in samples taken from malaria patients (41). To
determine the profile of PFA0210c expression throughout the
asexual intraerythrocytic cycle, extracts of synchronized
parasite cultures were prepared at regular intervals and exam-
ined byWestern blotting using a PFA0210c-specific mAb. This
revealed that the protein is detectable very soon (2 h) after inva-
sion, in accord with proteomic data indicating that the protein
is present in merozoites (39), and potentially pointing to a role
during invasion. The protein was undetectable during the early
trophozoite (ring) stage (14 h post-invasion), but by the mid-
trophozoite stage (26 h post-invasion), PFA0210c began to
accumulate, peaking at the late schizont stage (42–46 h post-
invasion) (Fig. 2A). This protein expression profile is similar to
the transcriptional profile of PFA0210c (36, 37), which shows
the lowest levels of transcript at late ring stages and a peak of
expression during schizogony. Interestingly, the Western blot
data showed that, as well as the 53-kDa putative full-length
PFA0210c gene product, several lower molecular weight prod-
ucts were detectable in parasite extracts, suggesting that the
protein may undergo proteolytic processing. To distinguish
between the possibilities that the lowermolecular weight bands
were proteolytic cleavage products or cross-reactive proteins,
we performed Western blot analysis on extracts of the trans-
genic P. falciparum strain PfBLD397, which in addition to the
endogenous PFA0210c gene expresses a second genomic copy
of the gene fused to a His6 tag, a triple HA tag, and GFP. In this
fusion protein, the His6-HA3-GFP module is inserted between
amino acids 117 and 118 of PFA0210c (see supplemental Fig. S2
for a description of the fusion). The gene encoding the fusion
protein (called PFA0210c-His6-HA3-GFP) under control of the
1938 bp of the native promoter region was inserted into the
genomic attB site in the 3D7-attB strain, and thus was expected
to be transcriptionally regulated similarly to the wild type gene.
When extracts of PfBLD397 were probed with the anti-
PFA0210c mAb, in addition to the band corresponding to the
wild type protein a prominent signal at90 kDa was detected,
corresponding to the expected molecular mass of PFA0210c-
His6-HA3-GFP. Importantly, several lower molecular mass
bands were detected below the PFA0210c-His6-HA3-GFP
band, in a pattern similar to the pattern detected below the
native PFA0210c signal (supplemental Fig. 2B). Probing the
PfBLD397 extract with anti-HA antibodies revealed the same
pattern of bands between 55 and 90 kDa. None of these species
were detected in extracts of the parental 3D7-attB parasite line
when probed with either antibody, indicating that the bands
represent cleavage products of PFA0210c-His6-HA3-GFP (sup-
plemental Fig. 2B).
To determine whether the cleavage of PFA0210c occurs
under physiological conditions within the parasite or is instead
the result of artifactual cleavage due to release of proteases dur-
ing extraction of parasite proteins, we mixed recombinant
MBP-PFA0210c-His6with schizontsprior to lysis andSDSextrac-
tion. Under these conditions, no proteolysis of the recombinant
protein was detectable, although the same PFA0210c-derived
proteolytic cleavage products as seen in Fig. 2Awere detected in
the parasite extracts (supplemental Fig. 2C). It was concluded
that limited proteolytic processing of PFA0210c occurs in vivo
within the parasite.
StarD7 has been shown to interact withmembranes (42–44),
presumably as a result of its role in transferring phospholipid to
membrane structures. To determine whether PFA0210c shares
similar characteristics, we next sought to determine whether
PFA0210c associates with membranes in the parasitized eryth-
rocyte. Using an extraction protocol that differentiates soluble
proteins from those peripherally associated with membranes
and integral membrane proteins (see “Experimental Proce-
dures” for details), we found that the lower molecular mass
forms of PFA0210c are present as soluble proteins in schizont
extracts, whereas the putative full-length form of the protein
possesses the characteristics of an integral membrane protein
(Fig. 2B). These findings are consistent with the predicted func-
tion of PFA0210c, and moreover raise the possibility that dif-
ferential post-translational processing may play a role in regu-
lating its association with membranes.
PFA0210c and Its PlasmodiumOrthologs Can Transfer Phos-
phatidylcholine—To investigate the potential phospholipid
transfer activity of PFA0210c, we expressed a portion of the
protein, including the putative START domain (residues 144 to
418) as well as the corresponding region from the Plasmodium
knowlesi (PKH_020910) and P. chabaudi (PCHAS_020730)
orthologs. All three recombinant proteins were produced as
fusions to MBP, and included a C-terminal His6 tag. The puri-
fied recombinant proteins were then tested for their capacity
to transfer phosphatidylcholine using a previously described
transfer assay in which donor vesicles consisting of phosphati-
dylcholine, phosphatidic acid, N-lactosylethanolamine, and a
radiolabeled phospholipid are mixed with acceptor vesicles
containing phosphatidylcholine and phosphatidic acid. After
incubation with recombinant protein to allow transfer of phos-
pholipids to occur, the donor and acceptor vesicle populations
are separated by agglutination and centrifugation of the donor
vesicles. The residual radioactivity in the supernatant, which
contains just the acceptor vesicles and the recombinant pro-
tein, reflects the amount of phospholipid transferred. As a
positive control for these assays we used the well described phos-
pholipid transfer protein PITP, which can transfer phosphatidyl-
inositol and phosphatidylcholine (45). As shown in Fig. 3A, all
three recombinantPlasmodium orthologs transferred PCat levels
similar to that of the control proteinPITP.No transfer activitywas
detected in the absence of acceptor vesicles, indicating that the
observedactivity reflects transfer toacceptorvesiclesand isnot the
result of association of radiolabeled lipid with the input recombi-
nant protein (Fig. 3B). However, when a 10-fold higher level of
transfer proteinwasused in this assay, accumulationof radioactiv-
ity could be detected in the supernatant, at significantly higher
levels than that accumulatedwhen the samehigh concentrationof
MBP-LacZwasadded, indicating that theproteincanbinddirectly
to radioactive lipids (Fig. 3B).
Importantly, substitution of Trp-227, one of the highly
conserved START domain residues (Fig. 1), with an Ala res-
idue virtually abolished the transfer activity of recombinant
PFA0210c. Substitution with Ala of another highly conserved
PFA0210c Is a P. falciparum Phospholipid Transfer Protein
31976 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 288•NUMBER 44•NOVEMBER 1, 2013
 by guest on July 28, 2015
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
residue, Arg-324, led to a smaller decrease in activity, as did Ala
substitution of Trp-284, a residue that is conserved among the
Plasmodium orthologs, (Fig. 3C) (the corresponding residue in
StarD7 is a Tyr residue).
Measurements of the time dependence of the phospholipid
transfer reaction showed that the initial rate of transfer was
0.34 pmol/min/g of protein (Fig. 3D), which is of the same
order as that measured for PITP (not shown). Similarly, we
measured the concentration dependence of the reaction.
Although this varied somewhat between different batches of
recombinant protein, we found that even at concentrations as
low as 0.5 g/ml, significant levels of transfer could readily be
detected in a 30-min transfer assay (Fig. 3E). Together these
results provide evidence that PFA0210c can transfer phosphati-
dylcholine between phospholipid vesicles and hence act as a
bona fide phospholipid transfer protein.
The Entire STARTDomain of PFA0210c Is Required for Phos-
pholipid Transfer Activity—All orthologs of PFA0210c contain
a polypeptide sequence in addition to the annotated START
domain, although as observed above this sequence is not highly
conserved between the orthologs (supplemental Fig. S1). To
explore whether the additional sequence plays a part in phos-
pholipid transfer activity and to determine theminimal domain
required for phospholipid transfer, we produced C-terminal
and N-terminal truncations of PFA0210c and assessed them
using the radioactive phospholipid transfer assay. TheN termi-
nus of the protein contains the signal sequence (amino acids
1–24) and the HT motif (amino acids 60–65), which are likely
removed during the course of export (46). Similarly, as the
region immediately following the HT has been shown to be
important for export (14, 15, 47), it is unlikely to have a role in
the function of the exported protein. Furthermore, the segment
FIGURE 3. PFA0210c and its orthologs possess phosphatidylcholine transfer activity. A, phosphatidylcholine transfer activity of PFA0210c and its
orthologs, PKH_020910 and PCHAS_020730. Phospholipid transfer was measured by the transfer of radioactive phosphatidylcholine from donor vesicles to
acceptor vesicles as described under “Experimental Procedures.” The phosphatidylinositol transfer protein PITP is included as a positive control. TheMBP-LacZ
fusion and the no protein samples serve as negative controls. B, PFA0210c can bind phospholipids directly. A transfer assay was set up as in A, except that no
donor vesicles were added. At the concentration of protein used in the experiment in A, no accumulation of radioactivity in the supernatant is detected, but
adding 10-foldmore protein results in accumulation of radioactivity in the supernatant.Numbers below the axis indicate the concentration ofMBP-PFA0210c-
His6 in g/ml. C, transfer activity of point mutants of PFA0210c. Phosphatidylcholine transfer of PFA0210c carrying a mutation at the indicated position was
measured using the same assay as in panel A. Note that mutation of the highly conserved residue Arg-324 (see Fig. 1) does not fully inactivate the protein. D,
time dependence of phosphatidylcholine transfer by PFA0210c. The concentration of PFA0210c used was 5g/ml. E, dose dependence of PFA0210c-depen-
dent phosphatidylcholine transfer. Numbers below the axis indicate the concentration of MBP-PFA0210c-His6 in g/ml.
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between amino acid residues 65 and 99 is not conserved
between PFA0210c and its Plasmodium orthologues, making it
unlikely that it has a conserved function. For our analysis of the
functional domain of PFA0210c, we therefore used recombi-
nant constructs starting at amino acid residue 99. Our assays
showed that recombinant proteins containing amino acid
residues 99, 123, or 144 (PFA0210cN99, PFA0210cN123, and
PFA0210cN144, respectively) as the N-terminal residue can
transfer phospholipids, although the transfer activity of
PFA0210cN144 was slightly lower than that of PFA0210cN99
and PFA0210N123. When PFA0210c was truncated further, as
in the cases of PFA0210cN168 through PFA0210ccN290, no
transfer activity was detected. PFA0210cN99, PFA0210cN123,
and PFA0210cN144 contain the entire annotated START
domain, whereas PFA0210cN168 through PFA0201cN290 lack
increasingly large portions of the STARTdomain (Fig. 4A). The
slightly decreased activity of PFA0210cN144 could be the result
of the close proximity of theMBP portion of the fusion protein.
A C-terminal truncation that terminates at residue 384
(PFA0210cC384), the exact end of the annotated START
domain, was found to be as active as PFA0210cC418, which
terminates at residue 418. In contrast, PFA0210cC336, which
only includes the sequence up to residue 336, and thus lacks
more than 49 residues of the C-terminal portion of the START
domain, was completely inactive in the transfer assay (Fig. 4B).
We concluded that the minimal phospholipid transfer domain
of PFA0210c is defined by amino acids 144–384, showing that
the START domain of the protein contains all the structural
requirements for transfer activity.
PFA0210c Can Transfer Multiple Phospholipids—Most
phospholipid transfer proteins display a profound preference
for specific phospholipids, although some can transfer several
different phospholipids (49). To test the ability of PFA0210c
and the P. knowlesi and P. chabaudi orthologs to transfer phos-
pholipids other than PC, we initially tested which phospholip-
ids could be transferred by PKH_020910 and PCHAS_020730
in a permeabilized cell assay. In this assay, the test protein is
incubated with permeabilized cells that have been labeled with
[14C]acetate, and therefore contain a wide variety of radiola-
beled phospholipids, in the presence of acceptor vesicles. After
separation of the cells and the acceptor vesicles, the identity of
the phospholipids transferred to the vesicles can be determined
by analytical TLC. This revealed that PKH_020910 and
PCHAS_020730 can transfer phosphatidylethanolamine, phos-
phatidylinositol, and phosphatidylserine in addition to phos-
phatidylcholine (Fig. 5, A and B). Minimal transfer activity was
detected in the presence of MBP-LacZ or in the absence of
protein. To verify that PFA0210c can also transfer phosphati-
dylethanolamine and phosphatidylinositol, we produced donor
vesicles containing purified 14C-labeled phosphatidylethanol-
FIGURE4.Thephosphatidylcholine transfer activity of PFA0210c resideswithin theSTARTdomain.A,phosphatidylcholine transfer activity ofN-terminal
truncations. The transfer activity of versions of MBP-PFA0210c-His6 containing a portion of PFA0210c beginning at the indicated N-terminal residue were
testedusing the same transfer assay as described in the legend to Fig. 3A. PFA0210cN99, PFA0210cN123, andPFA0210cN144 contain the entire STARTdomain;
PFA0210cN168 through PFA0210cN290 lack increasingly large portions of the START domain. B, phosphatidylcholine transfer activity of C-terminal trunca-
tions. The transfer activity of theMBP-PFA0210c-His6 containing the indicated region of PFA0210cwas tested. The versions (or constructs) containing residues
144–384 and 144–418 contain the entire START domain.
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amine or phosphatidylinositol. PFA0210c was able to transfer
both of these phospholipids (Fig. 5C), whereas the control pro-
tein PITP was able to transfer only PI, as expected (45). In addi-
tion, PFA0210c was also able to transfer sphingomyelin, similar
to PITP, which has previously been shown to transfer sphingo-
myelin (50). This result strongly suggests that PFA0210c and its
Plasmodium orthologs have the capacity to transfer multiple
phospholipids.
To estimate the relative affinities of PFA0210c and its
orthologs for different phospholipids, we compared the ratios
of radioactive phospholipids in both the HL60 cell extracts and
acceptor vesicles used in Fig. 5, A and B. To do this, we arbi-
trarily used levels of transferred phosphatidylinositol as a refer-
ence, assigning a value of 1 to that value and then determining
the relative levels of the other radiolabeled phospholipids in the
HL60 cell extract compared with those transferred to acceptor
vesicles. Comparison of these two ratios for each phospholipid
then allowed for a comparison of the relative efficiency of trans-
fer. The analysis revealed that the relative level of phosphatidyl-
choline in the cells and vesicles was very similar to that of phos-
phatidylinositol, and that the level of phosphatidylserine was
only slightly decreased in the vesicles (Table 1). However, the
level of phosphatidylethanolamine in the vesicles was reduced
about 3-fold compared with the level of phosphatidylethanol-
amine in theHL60 cell extract, indicating that PFA0210c ortho-
logues have a relative affinity for phospholipids as follows: PI
PC  PS  PE. As phosphatidylserine is found exclusively in
the inner leaflet of the cell plasma membrane, we judged that
the test proteins must have had access to the cytosol of HL60
cells during the course of the assay. The lower levels of transfer
of phosphatidylethanolamine therefore did not result from a
lack of access of the transfer protein to the phospholipid. Levels
of other phospholipids in the HL60 cell extract were too low to
be used for the determination of the relative transfer efficiency
(data not shown).
Localization of PFA0210c-GFP—To obtain insight into the
possible role of PFA0210c in the parasite, we sought to deter-
mine its subcellular localization. Our previous study that
reported export of PFA0210c used a C-terminal fusion to GFP
expressed under control of the strongP. falciparum calmodulin
promoter (11). To confirm that the PFA0210c-His6-HA3-GFP
fusion can also be exported, we produced a new construct
designed to express PFA0210c-His6-HA3-GFPunder control of
the calmodulin promoter and introduced this into P. falcipa-
rum. GFP fluorescencewas readily detected in the cytosol of the
resulting parasite line (Fig. 6A), confirming that PFA0210c is an
exported parasite protein. Examination of PFA0210c-His6-
HA3-GFP expressed in synchronized PfBLD397 parasites at
28 h post-invasion (early trophozoite stage) revealed a much
lower level of fluorescence (likely due to its expression from the
native PFA0210c promoter in these parasites) and the erythro-
cyte cytosol signal was not obvious, likely due to fluorescence
quenching by host cell hemoglobin. However, the visible GFP
signal was still concentrated in a circular pattern indicative of
localization in the PV (Fig. 6B), again confirming export beyond
the parasite plasma membrane. Interestingly, examination of
mature PfBLD397 schizonts revealed the fusion protein to be
localized primarily in small compartments surrounding the
edge of the parasite, suggesting that it could be transferred to an
apical organelle in mature developmental stages (Fig. 6C). This
is consistent with the finding that PFA0210c can be detected in
merozoites (39).
FIGURE 5. PFA0210c and its Plasmodium orthologs can efficiently transfer several different phospholipids. A, phospholipid transfer from radiolabeled
HL60 cells to acceptor vesicles by PKH_020910 and PCHAS_020730. Transfer of phospholipids from the cells to the acceptor vesicles was set up as described
under “Experimental Procedures” and the lipids transferred were identified by analytical thin layer chromatography, followed by exposure of the TLC plate to
a phosphorimager screen. B, quantitation of the phospholipid transfer detected in panel A. Background values of theNo protein sample were used as baseline
and were subtracted from the values of the transfer by the Plasmodium proteins and the control protein. Quantitation was performed as described under
“Experimental Procedures.” C, transfer of phosphatidylethanolamine, phosphatidylinositol, and sphingomyelin by PFA0210c was measured using the same
transfer assay as in Fig. 3A, except that radioactive phosphatidylethanolamine, phosphatidylinositol, or sphingomyelin was incorporated into the donor
vesicles. Thehigher background levels of transfer seen in thenegative controls in the case of phosphatidylethanolamine andphosphatidylinositol likely reflect
the presence of impurities within the preparations of the radioactive lipids (see “Experimental Procedures”).
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To finally determine whether native, unmodified PFA0210c is
exported during the stage of the life cycle shown in Fig. 6A, we
treated P. falciparum-infected erythrocytes with streptolysin O,
which permeabilizes the erythrocytemembrane but not the PVM
andso selectively releasesproteinspresent in the erythrocyte cyto-
sol (23).WefoundthatuponstreptolysinOtreatment,overhalfofthe
PFA0210c was released into the supernatant (supplemental Fig. S3).
In contrast, a much smaller fraction of the PV resident protein
PfPV1 (51)was released (supplemental Fig. S3), indicating that the
PVM remained largely intact during streptolysin O treatment.
Together, these experiments show thatPFA0210c is present in the
PV and is also exported into the erythrocyte during the trophozo-
ite stage and that it is recruited into a parasite organelle during
schizogony.
DISCUSSION
Previous identification by us and others of the full comple-
ment of P. falciparum proteins that are exported to the host
erythrocyte has revealed that interactions between the parasite
and its host cell are much more complex than previously
TABLE 1
Relative phospholipid content of HL60 cells and vesicles after incubation with PKH_020910 and PCHAS_020730. Phosphatidylinositol was used as
standard; values reflect the ratio of the indicated phospholipid to phosphotidylinositol. Datawere taken from the experiment shown in Fig. 5A
HL60 PKH_020910 HL60/PKH_020910 PCHAS_020730 HL60/PCHAS_020730
Phosphatidylinositol 1 1 1 1 1
Phosphatidylcholine 5.11 4.92 1.04 4.91 1.04
Phosphatidylethanolamine 1.51 0.55 2.75 0.56 2.70
Phsophatidylserine 0.41 0.35 1.17 0.37 1.11
FIGURE6.PFA0210c is anexportedP. falciparumprotein.A, thePFA0210c-His6-HA3-GFP fusion canbeexported into theerythrocyte cytosol. InP. falciparum
strain PfBLD390, which produces the same GFP fusion as PfBLD397, but where expression is controlled by the stronger calmodulin promoter, the GFP fusion
is detected in the erythrocyte cytosol, indicating export beyond the PVM boundary. B and C, PfBLD397, expressing a fusion of PFA0210c to GFP controlled by
its native promoter (see supplemental Fig. S2 for description of the fusion), was imaged at the early trophozoite stage (28 h after invasion; panels in B) and the
schizont stage (46 h after invasion; panels in C). In the trophozoite stage, the protein is present in the characteristic circular pattern of the PV. In the schizont
stage, the protein is recruited to organelles within the parasite.
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thought. However, in only a very few cases is the function of
exported proteins known. Here we have focused on the bio-
chemical function of PFA0210c, an exported protein that is
conserved among Plasmodium species and therefore likely per-
forms a conserved role. Bioinformatic analysis showed that this
protein is a member of the START domain-containing family.
This was confirmed experimentally by functional assays that
showed that PFA0210c can transfer phosphatidylcholine, phos-
phatidylethanolamine, phosphatidylinositol, and sphingomy-
elin between phospholipid vesicles. This action appears to be
rapid and is mediated with an efficiency quantitatively similar
to that of the well described phosphatidylinositol transfer pro-
tein PITP. No binding of fatty acids by PFA0210c was detected
in a fatty acid-binding assay (not shown), indicating that the
activity of PFA0210c is specific for phospholipids.We conclude
that PFA0210c is a bona fide phospholipid transfer proteinwith
a broad specificity for phospholipid transfer. Orthologs from P.
knowlesi and P. chabaudi displayed the same phospholipid
transfer activity, and therefore phospholipid transfer is likely a
conserved requirement for all Plasmodium parasites. As all
known PFA0210c orthologs contain an HT/PEXEL export
motif, the phospholipid transfer activitymediated by these pro-
teins is likely to be an important function in the infected eryth-
rocyte. Transgenic expression in P. falciparum of PFA0210c
and streptolysin O-mediated permeabilization experiments
confirmed that PFA0210c is an exported protein.
The precise role of PFA0210c and its orthologs remains to be
determined. The non-parasitized mature erythrocyte is devoid
of internal membranes, so the membrane-bound compart-
ments in the infected erythrocytes, the tubovesicular network,
the Maurer clefts, and the PVM must be made de novo. As the
surface area of the parasitized erythrocyte does not change
much as the parasitematures (52), the parasite itself is the likely
source of these membranes and the phospholipids that form
them. There is no evidence that these compartments are con-
tiguous with the plasma membrane of the parasite, necessitat-
ing a transport system for the phospholipids. As there is no
evidence for vesicular transport directly from the parasite
plasmamembrane into the PV, we propose that PFA0210cmay
deliver the phospholipids required for the expansion of the PV.
The tubovesicular network appears to be contiguous with the
PVM (53, 54), and although the attachment of theMaurer clefts
to the PVM remains unclear (55–57), as an exported protein,
PFA0210c could provide the building blocks for all the internal
organelles. This hypothesis requires rigorous genetic and bio-
chemical evaluation, a focus of ongoing work. It should be
noted that the obligate intracellular parasiteChlamydia tracho-
matis appears to use a similar strategy to obtain sphingomyelin
for the expansion of the membrane-bound compartment
(inclusion) in which it resides by recruiting the host ceramide
transfer protein to the inclusion to obtain ceramide synthesized
by the host cell (48, 58). Attempts to delete the PKH_020910
gene in P. knowlesi have been unsuccessful,5 providing prelim-
inary evidence that the protein is essential. As the sequence
outside of the START domain is not well conserved, the func-
tion of these parts of the protein also requires further
investigation.
This study has shown that in depth bioinformatic analysis sup-
plemented by biochemical analysis can establish biochemical
functions of exportedPlasmodium proteins, in this case phospho-
lipid transfer. Studyof additional exportedproteins in thismanner
maybegin toprovide amore completepictureof the interactionof
the malaria pathogen with its host erythrocyte.
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